This paper discusses the effectiveness of two animal composters in containing diseases caused by spore-forming bacteria.
Pareto charts of exposures during carcass disposal allow policy interventions to be better designed.
This guide is based on the experience of SOLIDARITÉS INTERNATIONAL. It consists of 3 parts:
1. General information on cholera
2. Before and between epidemics
3. Response to cholera epidemics
These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza.
This Checklist is designed to help hospitals assess whether their antimicrobial stewardship programs (ASPs) contain core essential elements for success.
This study highlights the changing safety and security landscape engendered by the emergence of new genome editing technologies, helps policy-makers and other stakeholders navigate this space, and illuminates broader trends in the life sciences that may impact the biosecurity landscape.
This tool enables pig producers to evaluate areas for biosecurity improvement on their farms by completing a short questionnaire based on African swine fever (ASF) virus scientific literature and practical experience, intended to help reducing the ASF introduction risk level.
The National Strategy for Countering Weapons of Mass Destruction (WMD) Terrorism is designed to achieve a set of strategic objectives whose common purpose is to greatly reduce the probability that extremist groups and individuals will conduct attacks using WMD.
Biodefense in the Age of Synthetic Biology explores and envisions potential misuses of synthetic biology. This report develops a framework to guide an assessment of the security concerns related to advances in synthetic biology, assesses the levels of concern warranted for such advances, and identifies options that could help mitigate those concerns.
This software allows laboratory directors and emergency planners to estimate the daily number of specimens expected to be received for testing and the laboratory’s testing capacity during each pandemic stage.